BRENDA VARELA: Open Payments
NPI 1356771745 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$253 in 12 payments from 10 companies in 2025. Trend: 2023 $393 · 2024 $385 · 2025 $253
Food & beverage: $253
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $41 |
| Merck Sharp & Dohme LLC | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| Genentech USA, Inc. | 1 | $26 |
| Incyte Corporation | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $21 |
| EMD Serono, Inc. | 1 | $21 |
| ARRAY BIOPHARMA INC | 1 | $20 |
| PFIZER INC. | 1 | $18 |
Products named: KISQALI, Polivy, KEYTRUDA QLEX, MONJUVI, ENHERTU, INJECTAFER, ERLEADA, DARZALEX.
Industry payments across CA — which companies pay providers there.
